DARE Study
1st May 07
The five-year DARE study will analyse the genetic make-up of patients who have developed the potentially fatal condition after taking certain medications, to see if scientists can spot a pattern.
Patients in 300 acute trusts across
A team of three nurses are travelling up and down the
Already researchers have pinpointed at least 25 prescription drugs linked to arrhythmia.
Ventricular arrhythmias, disturbances of normal heart rhythms, can lead to blood clotting and strokes. They can cause fatalities through rhythm disorders of the heart such as prolongation of cardiac repolarisation, torsades de pointes and ventricular fibrillation.
The study is a collaboration between
The research is led by Professor John Camm and Elijah Behr. Professor Camm said: "What we want to do is detect a genetic reason for these reactions and determine whether it will be possible to predict which patients will be vulnerable to specific drugs.
"Fatal reactions to certain medications have generated public and medical concern due to their unpredictability, and the lack of understanding of their epidemiological and clinical significance. Drugs such as astemizole and prenylamine have been withdrawn from the market because of this side-effect.
"The findings will result in safer prescribing and drug development."
For more information, contact media@sgul.ac.uk or to receive an alert every time we upload a news story, subscribe to the RSS feed here.

